Evidence map›Paper›PMID 31439922›Full record

ArticleScientific reports2019

Crystal structures of cholera toxin in complex with fucosylated receptors point to importance of secondary binding site.

Joel B Heim, Vesna Hodnik, Julie E Heggelund, Gregor Anderluh, Ute Krengel

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Recent development of oral vaccines (Review).Experimental and therapeutic medicine · 2024
    Review
  11. UsingBiochemistry · 2024
    Article
  12. Article
  13. The diverse landscape of AB5-type toxins.Engineering microbiology · 2023
    Review
  14. UsingbioRxiv : the preprint server for biology · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Frontiers in medicine · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Joel B HeimDepartment of Chemistry, University of Oslo, P.O. Box 1033, NO-0315, Blindern, Norway.ORCID http://orcid.org/0000-0001-9702-9480
Vesna HodnikDepartment of Biology, Biotechnical Faculty, University of Ljubljana, Jamnikarjeva 101, 1000, Ljubljana, Slovenia.ORCID http://orcid.org/0000-0002-7681-038X
Julie E HeggelundDepartment of Chemistry, University of Oslo, P.O. Box 1033, NO-0315, Blindern, Norway.ORCID http://orcid.org/0000-0001-7805-1754
Gregor AnderluhDepartment of Molecular Biology and Nanobiotechnology, The National Institute of Chemistry, Hajdrihova 19, 1000, Ljubljana, Slovenia.ORCID http://orcid.org/0000-0002-9916-8465
Ute KrengelDepartment of Chemistry, University of Oslo, P.O. Box 1033, NO-0315, Blindern, Norway. ute.krengel@kjemi.uio.no.ORCID http://orcid.org/0000-0001-6688-8151
University of Oslo · NONational Institute of Chemistry · SIUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholera is a life-threatening diarrhoeal disease caused by the human pathogen Vibrio cholerae. Infection occurs after ingestion of the bacteria, which colonize the human small intestine and secrete their major virulence factor - the cholera toxin (CT). The GM1 ganglioside is considered the primary receptor of the CT, but recent studies suggest that also fucosylated receptors such as histo-blood group antigens are important for cellular uptake and toxicity. Recently, a special focus has been on the histo-blood group antigen Lewis

Indexed as

Binding SitesBlood Group AntigensCholeraCholera ToxinGlycosylationG(M1) GangliosideHumansProtein BindingVibrio choleraeBlood Group AntigensCholera Toxinfucosyl GM1 gangliosideG(M1) Ganglioside

Identifiers

PMID31439922
PMCPMC6706398
OpenAlexW2969662953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.